
06/25/2025
WATCH: Dr. Massimo Cristofanilli spoke with CURE Today about targeting ESR1 mutations early on in an effort to improve outcomes
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.